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Summary. Stroke is a global problem with increasing significance because of the ageing population. Except for age, 
hypertension is by far the most important risk factor for stroke. Hypertension predisposes to a number of intracerebral 
and extracerebral vascular lesions which may cause cerebrovascular events by different mechanisms. The high 
metabolic need and low energy reserve make the braiavery vulnerable to ischaemia. During the last decade a number 
of experimental studies - supported by PET studies in man - suggest the presence of a therapeutic window, i.e. the time 
during which the neurons can be saved. The penumbra is the zone surrounding the core of the infarct where the flow is 
decreased and the neurons are lethargic and may be electrically silent but still viable. The presumed role of calcium, 
excitatory amino acids, free radicals, platelet-activating factor, acidosis and brain temperature in the process of 
neuronal death is briefly reviewed. 
Keywords : Ischaemia, Stroke, Hypertension, Atherosclerosis, Positron Emission Tomography (PET), Middle Cerebral 
Artery Occlusion (MCA), Reperfusion, Free radicals, Nitric Oxide (NO). 
Introduction 
As a consequence of the high rate of oxygen metabolism 
and the lack of tissue oxygen stores, interruption of 
oxygen delivery to the brain causes immediate cell 
dysfunction and rapidly leads to cell death. Oxygen 
delivery to the brain is defined as the product of the 
oxygen content of arterial blood and the cerebral blood 
flow. Inadequate oxygen delivery (hypoxia) can result 
from inadequate cerebral .blood flow (Ischaemic 
hypoxia), inadequate partial pressure of oxygen in 
arterial blood (hypoxic hypoxia), or inadequate oxygen- 
carrying capacity of arterial blood (anaemic hypoxia). 
The most common cause of brain hypoxia is ischaemia 
or inadequate cerebral blood flow. The level of cerebral 
blood flow at which the brain begins to exhibit energy 
failure is fairly well defined. Reduction of cerebral 
blood flow below 15ml/min/lOOg of tissue results in 
failure of electrical activity, and a reduction to less than 
10ml/min/100g of tissue results in loss of the 
transmembrane ionic gradient. Cellular energy depletion 
appears to be a triggering event for many of the 
damaging biochemical processes occurring during 
ischaemia. 
There are many causes of cerebral ischaemia in humans, 
including head trauma, stroke and cardiac arrest. 
Cerebral ischaemia may be further divided into focal and 
global categories. In global ischaemia, blood supply to 
the entire brain is interrupted, e.g., cardiac arrest. In 
focal ischaemia, blood supply to a particular region of 
the brain is interrupted, usually representing the area 
supplied by a particular vasculature. Cerebral ischaemia 
may also be described as complete or incomplete. 
Conlplete ischaemia is defined as total absence of blood 
flow to the entire brain or region of the brain. 
Incomplete ischaemia, on the other hand is defined as a 
severe reduction of cerebral blood flow in a focal or 
global pattern. Ischaemia may result in reversible cell 
injury or may be sufficient to cause tissue -death 
(infarction) depending on the duration and severity of 
ischaemia. Not all regions of the brain are affected in 
the same manner during global ischaemia. The most 
sensitive, i.e., selectively vulnerable, neurons are located 
in the CAI, CA3 and CA4 regions of the hippocampus, 
portions of the caudate and cerebellum and layers 3, 5 
and 6 of the neocortex. The mechanisms responsible for 
this selective vulnerability are not clear. In focal 
ischaemia, the anatomical location and extent of 
ischaemic damage depend on the distribution of the 
blood vessels whose flow is limited and on the presence 
of collateral circulation. Damage resulting from focal 
ischaemia commonly occurs in a graded fashion because 
collateral circulation partially perfuses the area 
surrounding the ischaemic core. This .ischaemic 
'penumbra' may receive blood flow that is inadequate to 
preserve normal cellular function but adequate enough to 
allow recovery. The concept of the ischaemic penumbra 
is important because the compromised status of these 
areas may be improved if effective early intervention is 
achieved. The purpose of our study which is being 
conducted at Max Planck Institute for Neurological 
Research, Cologne, in conjunction with the Department 
of Biomedical Science, University of Malta, in part, is 
to find early indicators for many of the damaging 
biochemical processes occurring during ischaemia. 
Types and origins of stroke 
Stroke or apoplexy is defined as an abrupt onset of 
neurological symptoms and signs indicating a disturbed 
cerebral circulation and lasting for at least 24 h or 
leading to death earlier. If lasting for less than 24 h, the 
episode is called a transient ischaemic attack (TIA) and 
is not included in the stroke definition. In Europe and 
North America about 80 %. of strokes are caused by 
cerebral haemorrhages, the figures for haemorrhages 
being somewhat higher in East Asia. 
Infarction can be caused by occlusion of large 
extracranial or small intracranial arteries. Occlusions 
can be caused by locally formed thrombi, by emboli 
coming from the heart or from the carotid and vertebral 
arteries. Arterial dissection, induced by trauma or 
occurring spontaneously, may be an underdiagnosed 
cause of brain infarction, particularly in young patients. 
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Arterial dissection is often associated with localized 
headache or facial pain at or before the onset of 
neurological signs. Cerebral infarcts can also occur in 
connection with hypotensive episodes. 
Cardiac emboli have been reported to account for 
between 15 and 50 percent of cases; the wide range 
illustrates that the diagnosis often is uncertain. Atrial 
fibrillation is a well recognized risk factor for cerebral 
embolism and the most common causes are rheumatic 
and ischaemic heart disease. The frequency of stroke 
increases with the duration of fibrillation. Cardiac 
embolism as a cause of stroke increases with age and 
may constitute about half of the cases in patients > 75 
years of age. 
As an intrinsic intracranial source of strokes, lacunae 
reflect arterial disease of the small penetrating arteries 
supplying the internal capsule, basal ganglia, thalamus 
and paramedian regions of the brain stem. They are 
thought to account for about 15 to 20 percent of strokes. 
It is currently debated whether some lacunae are of 
embolic origin. 
Most intracerebral haemorrhages occur in the 
supratentorial compartment, mostly involving the basal 
ganglia and the thalamus. The second most common 
location is the subcortical white matter of the cerebral 
lobes. Less than 15 percent of the haemorrhages are 
located in the cerebellum or pons. The symptoms will 
depend on the location and the size of the haematoma. 
Although the onset is usually abrupt, both the focal 
deficit and the level of consciousness usually undergo a 
gradual worsening due to further bleeding and /or 
secondary swelling. Haematomas of moderate or large 
size are accompanied by decreased levels of alertness. 
Diagnosis 
The neurological symptoms and signs will depend on the 
vascular territory involved. Most infarcts are 
supratentorial with the vascular territory of the middle 
cerebral artery being most often affected. The clinical 
features sometimes suffice to differentiate acute 
haemorrhage from infarction. Classification of the 
ischaemic stroke into subtypes can, to some extent, be 
performed on clinical grounds. However, it is not 
possible, clinically, to definitely separate haemorrhages 
from infarction, as revealed by brain computed 
tomography (CT), which is now routinely used in most 
stroke centres. Small haemorrhages can give 
comparatively minor synlptonls or even transient 
symptoms. Whereas haemorrhages are seen on CT scan 
immediately after onset, brain infarcts may not be visible 
during the first days 'and, if small, may not be detected at 
all. A lumbar puncture, previously the investigation of 
choice to separate haemorrhage from brain infarction, is 
now less frequently performed in centres where CT is 
available, but might be of value in selected cases. 
Ancillary Methods 
1 )  Doppler techniques and ultrasound imaging techniques 
The Doppler techniques depend upon the reflection of a 
beam of sound of very high frequency by moving red 
blood cells. Doppler techniques are widely used for the 
diagnosis of cerebrovascular occlusive disease. The 
most commonly used technique is that of plotting the 
Doppler frequency shift against time. When stenosis is 
present, blood flow velocity increases in the stenotic 
portion of the vessel and is detected by an increase in the 
frequency of the Doppler shift signal. Turbulence distal 
to the stenosis produces a characteristic visual pattern. 
To visualize the carotid arteries, a two-dimensional 
ultrasound imaging technique is used. Currently, the two 
techniques (Doppler flow and imaging) are combined in 
real time, defining structure and flow. This technique is 
called Echo-Doppler. 
Transcranial Doppler ultrasonography is a non-invasive 
procedure for the assessment of intracranial cerebral 
circulation, allowing measurement of blood velocity in 
cerebral arteries at the base of the brain. However, since 
the diameter of the arterial lumen is unknown the blood 
flow cannot be determined. Despite this limitation, the 
method can be useful in answering specific questions 
such as detection of haemodynamically significant 
intracranial arterial stenosis. It is particularly useful in 
following changes in patients with subarachnoid 
haemorrhage who develop spasm, monitoring of brain- 
injured patients and intraoperative and postoperative 
monitoring of neurosurgical patients (Petty et al., 1990). 
2 )  Magnetic Resonance Imaging (MRI) 
The underlying principle of MRI is that many nuclei 
respond to the application of strong magnetic fields by 
absorbing and re-emitting radio waves, that can be 
detected and analysed and thus used to generate spectra 
indicating the concentration of various chemical species 
of these nuclei. Protons are among the most sensitive 
and abundant nuclei in biological tissues and have been 
widely used for MRI. Bone is not visualized and areas 
normally obscured by bone on CT scans are easily 
imaged. The resolution of grey and white matter is 
superior to that of CT scanning and cerebral infarction is 
evident much earlier, usually within 2 to 6 hours. 
However, CT is superior in early identification of brain 
haernorrhages and will probably continue to be the 
screening method at admittance of stroke patients. The 
recent development in MR angiography, MR diffusion 
weighted imaging, MR spectroscopy and functional MRI 
together with the higher time resolution and more widely 
accessible MRI than PET have made these techniques 
powerful tools in experimental and clinical stroke 
research (Baron, 1993; Neil, 1993). 
3)  Cerebral angiography 
Cerebral angiography involves the selective introduction 
of a water soluble contrast medium into the carotid or 
vertebral arteries. It is used predominantly to detect and 
evaluate extracranial anomalies, particularly carotid 
stenosis, to diagnose arterial dissection and arterial and 
arteriovenous aneurysms. 
4)  Single photon emission compnterized tomography 
(SPECT) and positron emission tomography (PET) 
In acute stroke, the nornlal coupling between cerebral 
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Fig 1 
A: Sequential quantilative PET images of an individual cat representing cercbral blood flow (CBF). cercbral oxygen consumprion 
(CMR02) and oxygcn ex[rncrion (OEF) before (control) imd at 3 time points afwr permanent left middlc ccrebral nnery (MCA) 
occlusion (0-lh. 3-4 h. 18-20 h). Progrcssivc dctcriorarion of oxygen consump[ion in the MCA rerriiory corresponds wid1 the 
sprcading of h e  arcn with incrcased OEF i d  finally lends [o henlodynamic and mc~abolic dcrangemenr. 
13: Reconstruc~ed OW surface views of thc Icft hemisphere (masked by con~rol CBF) ar the s m e  3 h n e  points showing dynamic 
pcnurnbra with progrcssivc mctnbolic derangemcnt. 
C: PET image of glucosc consumption (CMRGI) reprcscntii the area of rial C m G I  suppression at 18-20 h nfrer MCA occlusion 
and corrcsponding his[ological cross sec[ion showing thc arca of infarction a1 h c  same lune point. 
Adoprc.dj,-on2 Grofar 01 11 994) wit11 pn-missimr. 
blood flow and n~etabolism is not upheld. Without a 
concomitant detem~inat ion of the oxygen extraction or  
cerebral metabolism, it  is not possible to  determine the 
state of the tissue by cerebral blood flow studies alone. 
This has been illustrated in studies using PET alone 
(Wise et al.. 1983: Brooks. 1991; Heiss el a1 1992). In 
the early stage. the blood flow and the metabolism might 
be low bur oxygen extraction increased, suggesting [hat 
rhe tissue is still viable (Figl).  Later, particularly if the 
bIood flow is restored, hyperaernia occurs while the 
oxygen ex~rsct ion is low or  nil indicating that the rissuc 
is severely damaged. The  rate of spontaneous 
reperfusion increases gradually with time and occurs 
within the first two weeks after slroke onset in 77 per 
cent of patients with cortical inlarcts (Jorgensen el al.. 
1904). 
Examplcs of remote metabolic depression after focal: 
stroke have been observed w i ~ h  PET in man. Reduced 
metabolic activity can be seen in the cerebral hemisphere 
contralateral to cerebral infarcts, ipsilateral to thalarnic 
and lenticulo-capsular lesions. the thalamus ipsila~eral ro 
a cortical infarct. visual cortex distal to lesions of the 
optic radiation and the cerebellar cortex contrala~eral to 
supratentorial infarcts (crossed cerebellar diaschisis): 
The exact mechanisnl underlying rhese metabolic 
changes that usaually are accon~panied by changes in C T  
o r  MRI is not completely understood (Pappara er al.. 
1987; Ginsberg, 1990). 
Risk Factors  
The stroke incidence increases nmkcdly  with age. In a 
Swedish unselected population only 2 0 - ~ e r  cent-of firsr- 
ever stroke patients wcre below the age of 65 and half of 
 he patients were more than 75 years of age (Johansson 
et al., 1992). With the current ageing of the world 
- - 
population. w o k e  is likely to remain a major medical 
problem. 
Hypertension 
Hypertension is the most imponant risk factor for stroke. 
Hypertension predisposes to different types of  
intracerebral and extracerebral arterial lesions which 
may cause cerebrovascular events by different 
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mechanisms (Johansson, 1992). Hypertension leads to 
three main types of vascular changes: compensatory 
structural adaptation, degenerative vascular changes and, 
in the presence of other risk factors, to atherosclerosis. 
Structural Adaptations to hypertension 
When the blood pressure is increased abruptly to high 
levels in a previously normotensive individual, the 
autoregulatory capacity of the cerebral resistance vessels 
might be overcome and the blood flow increases. A 
stepwise increase in blood pressure will be tolerated. In 
chronic hypertension the vascular bed will adjust 
functionally and structurally to the increased load. The 
smooth muscle hypertrophy/hyperplasia will help to 
sustain wall tension and maintain adequate contractile 
function. In the cerebrovascular bed, an increased media 
thickness and lumen reduction has been observed over a 
large range of arterial sizes in vivo and in vitro, starting 
at rather large arteries. These changes will shift the 
autoregulatory curve to the right and protect the blood- 
brain barrier (S trandgaard, 1978; Johansson, 1989). 
Although the structural adaptations basically are 
beneficial in protecting the vessels and preventing 
haemorrhage and permeability changes, they constitute a 
risk for ischaemia distal to any stenosis or occlusion or 
when the blood pressure is rapidly decreased because of 
the increased peripheral resistance and reduced collateral 
capacity. In connection with an abrupt decrease in blood 
pressure in hypertensive individuals, infarction may 
occur in the border zones between the territories of the 
main cerebral arteries. These 'water-shed' infarcts 
constitute approximately 10 percent of all human brain 
infarcts (Torvik, 1984). 
Degenerative changes in hypertension 
Degenerative changes in the small intracerebral blood 
vessels will occur when the compensatory mechanisms 
are not sufficient to protect the smaller intracerebral 
vessels. When the vessels yield to the high pressure, 
extravasation of plasma constituents seems to be the first 
step in hypertensive degenerative lesions in the vascular 
wall and in the developnlent of brain lesions 
(Johansson,l992). Degenerative changes in the 
intracerebral arteries can lead to focal brain oedema, 
small lacunar infarctions or intracerebral haemorrhages 
due to intracerebral microaneurysms (Johansson,l992). 
Hypertension, atherosclerosis and other risk factors 
Hypertension is a risk factor for atherosclerosis. 
Vascular changes related to atherosclerosis or ageing are 
more pronounced in hypertensive individuals. The 
predominant sites, and usually earliest localization of 
atherosclerotic changes, are in the extracranial arteries. 
The second most common site is in the circle of Willis 
and with time, the changes may also occur in the smaller 
intracerebral arteries. This is reported to occur earlier in 
hypertensive than in normotensive individuals. 
Other risk factors include diabetes, cigarette smoking, 
impaired cardiac function and high hematocrit and 
plasma fibrinogen levels. About 10 percent of strokes 
are preceded by transitory ischaemic attacks. There are 
substantial race differences with higher incidence in 
Japan and China, and in the US in the black population 
than in the white. There is an association between stroke 
and alcohol intake in men, which partly but not 
completely can be attributed to coexistent hypertension. 
Although epidemiological studies are lacking, drug 
abuse, particularly amphetamine, heroin and 'crack', a 
cocaine preparation that is inhaled, have repeatedly been 
reported to be associated with stroke in young 
individuals. 
Several studies suggest that family occurrence of stroke 
is an independent risk factor. Homocysteinaemia, long 
known to be a risk factor in homozygotes, has in several 
recent studies been reported to be a risk factor in 
heterozypotes also. 
Animal models of cerebral ischaemia 
Animal models are required for detailed study of the 
pathophysiology of cerebral ischaemia. An 'ideal' 
animal model would have the following features: 
The animal model should closely mimic the 
development of the clinical insult in humans. 
The experimental insult should elicit similar 
responses in each individual animal tested; i.e., the 
insult should cause a reproducible injury. 
The model should be closely related 
physiologically; e.g., temperature, blood glucose, 
and blood pressure should be tightly controlled. 
The experimental animal pathology should be 
similar to that in humans. 
Obviously, there are no 'ideal' animal models and it must 
be clearly understood that no animal model exactly 
reproduces cerebral ischaemia in man. Animals do not 
readily develop the cardiovascular disease that 
commonly underlies stroke, nor do they duplicate the 
age, nutritional status, or drug history of patients who 
suffer from stroke or cardiac arrest. Furthermore, 
animals are usually anaesthetized, are paralyzed, and 
have undergone surgery, particularly craniotomy, all of 
which may profoundly alter tissue response. 
Reproducible models are not easily achieved because of 
anatomical and physiological variability, both within and 
among species. In addition, lack of strict control of 
physiological variables, e.g., brain temperature, can lead 
to misleading results. In spite of these limitations, 
numerous animal models (rats, rabbits, gerbils, cats, 
dogs, goats, pigs and monkeys) have been developed and 
provide meaningful data that can be applied to the 
understanding of cerebral ischaemia in humans. 
Experimental ischaemia is induced in animals by 
occluding vessels that perfuse the brain. Focal 
ischaemia is modeled by middle cerebral artery 
occlusion (MCA); in some models this is accompanied 
by occlusion of the ipsilateral common carotid artery. 
Models of ischaemia can be permanent (no reperfusion) 
or transient (allowing reperfusion). Models of global 
ischaemia are utilized to simulate ischaemic injury 
resulting from cardiac arrest. In large animals, global 
ischaemia has been modeled in numerous ways, 
including inducing cardiac arrest, using a neck 
tourniquet, cross-clamping the proximal aorta, and 
raising the intracranial pressure to levels greater than 
mean arterial blood pressure. Our experimental 
approach, for induction of focal cerebral ischaemia in cat 
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models involves occlusion of the proximal middle 
cerebral artery. Briefly, after enucleation, a small burr 
hole of 3-mm diameter is drilled transorbitally above the 
optic foramen in the posterior wall of the left orbit. The 
trunk of the left MCA is prepared just above [he o p ~ i c  
nerve by cutring dura and arachnoid membranes under 
microscopic control, and an occluding device (Graf et 
al.. 1986) is implanted around the MCA trunk. This 
devicc cons~s l s  of an outer cannula whose tip fornis a 
hook to be put around the MCA,  .and an inner occluder. 
which can slide into the hook hrough  the cannula. By 
pushing rhe inner occluder toward the silicon-coated 
wall of the hook, the MCA is compressed gently and 
firmly between the occluder and the hook wall, yielding 
roral arterial occlusion, and by pulling back the occludef, 
rhe M C A  occlusion is easily relieved. 
Animal models are necessary to study cerebral 
ischaeniia, and despite significant shortcomings, animal 
models have provided and will continue ro provide 
insights inro rhe pathophysiology of cerebral ischaemia 
which may lead to the development of effective 
phamiacological interventions. 
EfTects on bra in  tissue, mechanisms ol 'neuronal  
death,  post-ischaemic reperfusion 
As already menrioned earlier, the high nie~abolic need 
;md low energy reserve make the brain very vulnerable 
during ischaemia. When the perfusion pressure falls 
below critical levels, ischaeniia develops 'and will 
progress to infarction if the flow is sufficiently reduced 
and the reduction persists long enough. In experimental 
studies on focal brain ischaemia, surprisingly estensive 
restoralion of metabolism and function has been 
observed after ischaemic periods as long as 60 min or  
more. The length of  time tolerated varies wirh fnclors 
such as rhe degree of reflow after ischaemia, and plasma 
concentrations of glucose, corticosteroids and 
calecholarnines (see Figure 2). 
Currently [he penumbra is looked upon as  a dynamic 
process with impaired ;md unstable perfusion and 
metabolism which is the larger for possible I herapeulic 
intervention (Heiss and Graf. 1994). There is some 
disagreement as  to the time during which the tissue rnay 
be rescued but this is likely to be relaled to rhe degree of 
perfusion deficit and niay be up to a couple of hours. 
However, with long recovery periods, pernarnen t 
selective neuronal daninge is seen already in ischaemia 
of 5- 15n1in duration (Ito et al.. 1975). This 'maturation' 
of  neuronal damage following rransien~ global 
ischaemio, which has been verified in a number of 
studies, indiciltes an on-going process in the posr- 
ischaemic period. 
Clot resolution o r  recanatizarion of an occluded artery 
rnay occur sponraneously but the frequency is unknown. 
Animal as  well as clinical studies have demonsrraled rhal 
this will often lead to postischaeniic hyperaeniia. 
Wheras hyperaemia has been reported to be essential for 
the functional recovery in global ischemia, hyperae~nii~ 
has been associated wi[h pronounced o e d e n ~ a  nd severe 
brain damage after focal ischaen-lia. Prevention of 
hyperaemia reduces the vasogenic oedenln as well as the 
ischaeniic brain damage in focal ischaernin in 
Fig 2. Sequential PET uuagcs of a n  indiv idual  c;lr representing 
CMRCl bcforc (con[rol) and 81 2 time points after left middle 
cerebral artery occlusion (6 hours and 25 hours). Progressive 
dctcriorii~ion includes in [his case the hcrnisphe~ con~rala[cral 
10 the ischemic focus. probably due ro malignimt cderna 
formation and risc of'ilitr~~cranial pressure. 
[By L . O U I . I P . F ~  of Dr. R. Grac Mo.v Plutrk If?srirure j?w 
Nei[rological Re.rrurc/r. Cologtrr~, G c r t ~ a ~ y . ]  
experimental ;min~als. If conf im~ed  in man, these 
observations could be of' importance in clinical trials 
wilh fibrinolytic agenls and during operations on 
severely stenotic vessels where gradual rather than 
abrupt opening of an occluded vessel should be aimed at. 
However, in the clinical situation i~ wouId be a difficult 
task to decide if and when at te~npls  to reduce [he blood 
flow should be tried. An aggravating effecl of 
postischaemic hyperernia could be related LO any of the 
currently discussed mechanisms for nerve cell death 
following ischaeniia such as  free radicals. lactacidosis. 
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excitatory amino acids and possibly to some additional 
intrinsic or extrinsic factors. However, so far clinical 
studies have not confirmed that hyperaemia aggravates 
the lesions, rather hyperaemia has been proposed to be a 
prognostically good sign (Jorgensen et al., 1994; 
Marchal et al., 1993). Preliminary reports from studies 
on thrombolytic therapy in stroke indicate that it might 
be a smaller problem than expected. One possible 
explanation could be that the reflow does not occur so 
rapidly as under experimental conditions. Further 
studies are needed to clarify the possible adverse and 
beneficial effects of hyperaemia in stroke. 
One other problem that must be anticipated in ischaemia 
is the underlying neuronal damage. Since energy is 
required to uphold the ion gradients across nerve and 
glial cell membranes, energy failure will lead to a shift 
with efflux of K+ from cells and influx of Na+, C1- and 
Ca2+ . This ion shift will lead to an accumulation of 
water within the cells, an intracellular oedema. 
Accumulation of metabolites within the cell will add to 
this oedema, which in the early stage is completely 
reversible. Ischaemia leads to a diffuse transmitter 
release since energy is needed to keep transmitters stored 
in their granules. The electrical activity of the neurons 
stops when the blood flow is decreased to about one- 
third of the normal values (under normal temperature 
and blood glucose levels) but some basic cell function is 
still present and the cells can regain their function if the 
blood supply is restored. There are various hypotheses 
as to the  triggering mechanisms fcr neuronal death and 
some will be presented below. Current research 
indicates that these mechanisms combine in the process 
that finally kills neurons. The neuronal damage can be 
of two types:. selective neuronal vulnerability affecting 
groups of neurons with a characteristic distribution 
within the brain, and infarction, affecting not only 
neurons but also blood vessels and glial cells. 
The calcium hypothesis 
That cell death may be a specific consequence of 
disturbance in intracellular Ca2+ homeostasis has long 
been discussed (Schanne et al., 1979). The 
concentration of calcium is 10,000 times higher in the 
extracellular fluid than in the cells and influx of calcium 
into the cells together with release of calcium from 
intracellular sources leads to uncontrolled activation of a 
number of calcium-dependent reactions (Siesjo, 1992; 
Morley et al., 1994). The combination of energy failure 
and calcium influxlrelease can lead to an extensive 
breakdown of phospholipids and proteins, to proteolytic 
degradation of cytoskeleton components and to free 
radical formation. 
The excitotoxic hypothesis 
Glutamate and some other excitatory amino acids have a 
transmitter function in the brain but can also be toxic to 
the neurons. First, exposure of neurons to glutamate 
may cause an acute neuronal swelling resulting from the 
depolarization-mediated influx of Na+ C1-, and water. 
The degree to which this event contributes to neuronal 
injury is unclear, but it has been suggested that water 
entry causes osmotic lysis, which may disrupt neuronal 
function. 
In order to prevent a high extracellular concentration of 
glutamate and other excitatory amino acids, these are 
taken up by efficient re-uptake mechanisms after release. 
The uptake mechanisms are energy dependent and 
during ischaemia the excitatory amino acids may 
accumulate in high concentrations. Current evidence 
indicates that ischaemic neuronal damage may be caused 
by enhanced release or diminshed uptake of glutamate or 
other excitatory amino acids enabling an enhanced 
calcium influx through channels gated by excitatory 
amino acid receptors (Rothman and Olney, 1986; 
Hossmann, 1994). The elevation of intracellular Ca2+ is 
known to activate lipases, phospholipases, proteases, and 
protein kinases, each of which, if not properly regulated, 
can easily be envisaged to produce considerable cellular 
damage. Antagonists which block N-methyl-d-aspartate 
(NMDA) and alpha-amino-3-hydroxy-5-methyl- 
isoxazoleproprionic acid (AMPA) glutamate receptors 
have been shown to ameliorate neuronal damage in 
experimental ischaemia (Choi, 1990; Graham et al., 
1993). 
Free radicals 
The role of free radicals in the ischaemic nerve cell 
pathology has been debated for over a decade 
(Siesjo,1992; Chan, 1994). It has been suggested that 
free radicals are important particularly in the reperfusion 
period with good access to oxygen in an already 
damaged tissue. However, recent studies suggest a role 
also in permament ischaemia and free radical 
scavengers have been shown to reduce the infarct size in 
experimental brain infarction. Likewise, studies have 
shown that transgenic mice, overexpressing the enzyme 
Cu-Zn-superoxide dismutase, develop smaller infarcts 
than control animals (Chan et al., 1991). Calcium will 
enhance lipolysis and accumulation of arachidonic acid 
and interact with the free radical mechanisms in the 
degradation of lipids, proteins and DNA. Metals, 
including iron, increase the rate of lipid peroxidation and 
it has been suggested that free radical damage may also 
be related to alterations in iron-binding. 
Another factor thought to be of importance for ischaemic 
injury is platelet-activating factor which may act at least 
in part by generating free radicals (Lindsberg et al., 
1991). Since the metabolic needs of the brim increase 
with temperature, lowering of the brain temperature will 
lead to better survival of neurons during ischaemia. Free 
radicals also stimulate the release of elutamate in rat 
" 
hippocampal slices and neuronal cultures. This suggests 
that free radical formation and glutamate release are 
mutually related and cooperate in a series of molecular 
events that link ischaemic injury to neuronal cell death. 
The role of nitric oxide 
Nitric oxide (NO) has been regarded as one of the 
mediators playing a key role in the pathophysiologic 
mechanism of focal cerebral ischaemia (Dalkara and 
Moskowitz, 1994; Dawson, 1994). As expected from 
the complex and diverse actions of NO, studies 
attempting to modify NO production in focal cerebral 
ischaemia report conflicting results (Dalkara and 
Moskowitz, 1994; Dawson, 1994). Nitric oxide acts as 
an intercellular messenger molecule in the brain; it 
simply diffuses out of a cell where it has been 
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synthesized into the neighbouring cells 
where its targets exist (Dawson and 
Snyder, 1994). Like authentic 
neurotransmitters, NO must diffuse across 
the extracellular space to exert its 
biological effects, and thus extracellular 
NO concentration probably is a good 
indicator of physiologic NO activity. 
With the invention of NO-sensitive 
electrodes, real time measurements of 
extracellular NO concentration has 
become feasible. The first attempts to 
apply them to focal cerebral ischaemia 
have reported an increase in tissue NQ 
concentration (Malinski et al., 1993; 
Ohta et al., 1996) and NO is thus 
implicated as a mediator of tissue injury. 
Within 3 to 24 minutes after MCA 
occlusion, NO increases dramatically 
from approximately lOnM to 2.2 (M 
within cortex as detected by a porphyrinic 
microsensor (see Figure 3). Brain nitrite, 
cGMP levels and brain NOS activity 
increase as well (Malinski et al., 1993). 
Nitrite, NO and nitric oxide synthase 
(NOS) activity return to baseline levels 
within an how. One speculation holds 
that NOS activity increases due to a rise 
in intracellular Ca2+/calmodulin complex 
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Fig 3. Actual recording of systemic arterial blood pressure (BP), regional cerebral 
blood flow (rCBF), electrocorticogram (EcoG), direct current (DC) potential, 
extracellular Ca2+ concentration ([Ca2+],), and nitric oxide concentration (NO) in the 
ectosylvian gyrus. Middle cerebral artery (MCA) occlusion caused an immediated 
drop in rCBF accompanied by a steep negative shift of the DC potential and a sudden 
increase in NO (see arrows). Note that[Ca2+], showed a small elevation in the initial 
phase when NO increased, and that the steep fall [Ca2+], occurred much later at 160s 
after MCA occlusion. Adapted from Ohta et a1 (1997) with permission. 
synthesized from L-arginine and oxygen 
by NOS requiring NADPH, flavins and 
tetrahydrobiopterin. Among some isoforms, constitutive 
NOS is habitually present in neurons and endothelial 
cells in brain tissue, and is calcium/calmodulin 
dependent, ready to be activated by a small increase in 
cytosolic Ca2+ concentration (Dawson and Snyder, 
1994). In ischaemic tissue, cytosolic Ca2+ can be raised 
by Ca2+ influx through NMDA receptor-mediated Ca2+ 
channels and voltage-sensitive Ca2+ channels (Siesjo, 
1992). These Ca2+ channels require depolarization of 
the plasma membrane to let Ca2+ in, as in the case in 
ischaemic tissue. Intracellular Ca2+ stores, such as 
endoplasmic reticulum, must also be quoted as possible 
sources of a possible rise in cytosolic Ca2+ in the 
ischaemic tissue (Silver and Erecinska, 1990; Mitani et 
al, 1993). 
Although in normal brain NO seems to be a nontoxic 
mediator of cerebral vasodilation, recent data suggest 
that NO may have neurotoxic effects if present in 
abnormally high concentrations (Dawson et al., 1991). 
In endothelium and brain, ionized calcium is the 
intracellular messenger initiating the reduced 
nicotinamide-adenine dinucleotide-dependent oxidation 
of arginine to produce NO. It is well known that 
cerebral ischaemia causes an increase in extracellular 
concentration of glutamate and aspartate, and these 
excitatory amino acids bind to and stimulate NMDA 
receptors in brain (Beneviste et a1 ., 1984). Excessive 
activation of the NMDA receptors allows influx of Ca2+ 
into neurons, which may stimulate production of 
superoxide anion via a prostaglandin pathway and NO 
via stimulation of NOS. Stimulation of non-NMDA 
(Southam et al, 1991). Moreover, inhibition of NOS in 
neuronal culture ameliorates glutamate toxicity (Dawson 
et al., 1991). One postulated mechanism of NO toxicity 
is that at high concentrations, superoxide anion and NO 
may react to form the peroxynitrite anion, which 
decomposes at acidic pH into strong oxidants. Thus 
excessive NO generation might act as an agent of cell 
death in stroke by reacting with superoxide. 
In conclusion, the discovery of NO has provided a 
further opportunity to explore the pathophysiology and 
treatment of cerebral ischaemia. Controversy abounds, 
which may reflect the importance of NO to the diversity 
of factors (both known as well as unknown) which 
impact cerebral ischaemia. However, it would be of 
interest to determine whether drugs that alter NO 
synthesis and metabolism will be of use in the treatment 
of ischaemia. More to the point, one still needs to 
demonstrate whether NO is relevant to the 
pathophysiology of global ischaemia. Nevertheless, 
answers should be forthcoming from a number of 
developments, namley; 
selective inhibitors for the neuronal or vascular 
isoforms of NOS 
transgenic mice in which neuronal or endothelial 
NOS are selectively knocked-out 
discovery of new methods for both directly 
measuring NO and assessing NOS activity 
routine1 y . 
glutamate receptors is also thought to generate NO 
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Models of ischaemia and  reperfusion 
It is evident from evaluating different animal models of 
ischaemia and re~erfusion that a number of factors are 
important in determining the extent of neurological 
damage that occurs as a direct result of ischaemia. 
These include but are not limited to the amount of blood 
flow reduction, the duration of time that flow is reduced, 
the regional location of the flow reduction, and the 
metabolic state of the brain before the ischaemic period. 
Multiple mechanisms may contribute to the injury, and 
the relative contribution of each mechanism depends on 
the specific situation. For example, calcium-induced 
damage from the release of excitatory neurotransmitters 
is generally most prominent with moderate reductions of 
blood flow in regions with high NMDA receptors 
(Monaghan et al., 1985) and high excitatory amino acid 
innervation. With severe or complete reduction of blood 
flow, calcium entry through non-NMDA receptor- 
operated channels and voltage-sensitive channels 
becomes prominent (Siesjo et al., 1985). With reduced 
blood flow over prolonged periods, continued anaerobic 
glycolysis enhances the contribution of acidosis to 
ischaemic injury (Rehncrona et al., 1981). Therefore, 
when different potential mechanisms of ischaemia and 
reperfusion injury in brain are evaluated, it is important 
to recognize that the mechanism of injury will depend on 
the degree, duration, and localization of reduced blood 
flow and other aspects of the experimental model. 
Furthermore, the issue of radical-mediated injury is 
complicated because the various potential mechanisms 
are interrelated with radical injury. Acidosis can 
potentiate lipid peroxidation, calcium accumulation 
stimulates phospholipase activity, which may generate 
radicals via arachidonic acid metabolism; and NMDA 
receptor activation generates NO which in turn is 
capable of reacting with superoxide to forni the cytotoxic 
site of action. By blocking the entry of calcium ions, 
they may inhibit the essential role of this cation in the 
activation of lipolytic enzymes, protein kinases, and 
phosphatases during ischaemia. Improved cerebral 
blood flow, improved or no change in neurological 
outcome, decreased brain lactic acidosis, and decreased 
infarct size all have been reported following calcium 
channel blocker treatment in various studies (Wong et 
al., 1990). 
2) Vitamin E 
wTocophero1, a well known antioxidant, has beneficial 
effects on brain oedema and ischaemia. It inhibits the 
activities of phospholipase A2 and lipoxygenase and 
plays a fundamental role in the stabilization of 
polyunsaturated fatty acid chains in membrane 
phospholipids. Vitamin E interacts with cellular 
membranes and prevents lipid peroxide formation by 
acting as a hydrogen donor (Traystman et al., 1991). 
CDP-amines are key intermediates in the biosynthesis of 
phosphatidylcholine and phosphtidylethanolamine. The 
therapeutic actions of CDP-amines are thought to result 
from restorative effects on phospholipid synthesis in the 
ischeamic brain. CDP-amines attenuate the fatty acid 
increases and counteract the disruption of cerebral 
mitochondria1 lipid metabolism induced by hypnoxia. 
They have been reported to inhibit the activities of 
phospholipases A1 and A2. CDP-amines have also been 
reported to increase oxygen consumption and glucose 
incorporation into amino acids and phospholipids 
followed by a decrease in lactate production (Murphy et 
al., 1990). 
oxidants as exemplified before. 
4 )  Glutamate antagonist MK-801 
Thus it is an oversimplification to consider an array of 
parallel pathways that can be independently blocked for 
assessing the individual contribution of these injury 
mechanisms in the brain. 
Pharmacological intervention in ischaemia 
Despite major advances in deciphering the biochemical 
events involved in the pathophysiology of cerebral 
ischaemia, little has been done to arrest, prevent, or 
reverse ischaemic injury. It has been realized that the 
extent of irreversible damage is governed by both the 
duration of ischaemia and the severity of ischaemia 
(complete versus incomplete). A number of 
pharnlacological agents have been utilized for cerebral 
ischaemia in both animal models 'and humans, but to 
date, no agent has been shown to be of unequivocal 
value; i.e., there is no effective treatment for cerebral 
ischaemia, presently. However, a brief outline of the 
pharnlacological agents together with their proposed 
pharnlacological strategies for the treatment of cerebral 
ischaemia are listed below. 
I )  Calciurn channel hlocketx 
These drugs block the entry of calcium ions into the 
ischaemic neurons. These drugs do not themselves 
antagonize the effects of calcium ions; instead they 
prevent this ion from gaining access to its intracellular 
The use of MK-801 for the treatment of ischaemia is 
controversial. It has been used successfully for the 
treatment of cerebral ischaemia in experimental models. 
MK-801 may exert its antagonistic effects via a site 
related to the ion channel. The onset of NMDA receptor 
blockage with MK-801 is more rapid in the presence of 
glutamate. These two effects may be relevant to the 
efficacy of MK-801 in cerebral ischaemia, which 
provokes a marked elevation in extracellular 
concentrations of glutamate. In addition to direct 
receptor blockade, MK-801, may protect neurons with 
severe, but not complete, energy failure by preserving 
ionic gradients across the plasma membrane and 
enhancing amino acid uptake (Buchan, 1990). 
5 )  S~lpero.vide dismutase 
SOD has been proposed as a therapeutic agent for 
reperfusion injury because of its ability to scavenge 
superoxide anion. However, Cu-ZnSOD, is a large 
water soluble molecule (32 kDa) and therefore cannot 
penetrate the blood-brain barrier in significant quantities. 
In addition, SOD has a circulatatory half-life of only 8 
mins in rats. In an effort to overcome these problems, 
Traystman (1991) conjugated this enzyme 'and 
administered it intravenously in rats as liposome- 
entrapped SOD and polyethyleneglycol-conjugated SOD. 
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SOD delivered in liposomes has been shown both to 
increase brain SOD activity and to reduce infarct volume 
in a rat model of focal cerebral ischaemia. In contrast, 
polyethylene glycol-conjugated SOD does not appear to 
increase brain SOD activity but has been shown to 
reduce infarct volume in animal models of focal cerebral 
ischaemia. 
6 )  Platelet-Activating factor antagonist 
Large amounts of platelet activating factor (PAF) are 
produced by brain tissue and endothelium cells in 
response to ischaemia and reperfusion. PAF is a 
powerful vasoconstrictor and has many cytotoxic 
properties. PAF antagonists that are present in an extract 
of Ginkgo biloba leaves (ginkgolide B) appear to reduce 
edoema and neuronal damage in several mammalian 
species (Braquet et al., 1989). 
7 )  U74006F. 21 -Aminosteroids (Lazaroids) 
U74006F, a nonglucocorticoid 21-aminosteroid, is a 
potent inhibitor of lipid peroxidation. It has a beneficial 
effect in animal models of severe head injury, 
posttraumatic spinal cord ischaemia, and cerebral 
ischaemias. The mode of action of 21-aminosteroids is 
not known, but it may act by inhibiting iron-dependent 
lipid peroxidation. The 21-anlinosteroids significantly 
reduce Na2+ accumulation, K+ loss, and water entry into 
ischaemic brain. The effect was found to be most 
consistent and prominent in tissues surrounding the 
infarct site (Hall et al., 1990). 
8)  Cholesterol-lowering agents and oestrogen 
Two agents that are in routine clinical use - inhibitors of 
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) 
reductase or 'statins' (Cholesterol-lowering agents), and 
oestrogen have been shown to reduce brain vulnerability 
to focal ischaemic insults (Endres, 1998). It is thought 
that the fomler may work largely by upregulating the 
activity of endothelial NOS; the mechanism of 
oestrogen-induced neuroprotection is unknown, but it 
may involve antioxidant actions or amplification of 
trophic mechanisms. 
Future therapeutic directions 
Advances in methods of brain imaging, such as magnetic 
resonance imaging and positron emission tomography, 
should allow more accurate delineation of tissue regions 
at risk because of impaimlent of blood supply, but not 
irreversibly damaged, and so will enhance the targeting 
of counternleasures in time and space. One can 
anticipate continued refinement in thrombolytic 
strategies, aiming to iimit side effects at locations remote 
from the offending thrombus and thereby reducing 
bleeding complications, as well as more powerful 
approaches aimed at reduciiig brain oedema, or 
favourably altering the distribution of blood flow in 
cerebral arteries. 
With regard to neuroprotection, it is predicted that 
several paths of research will gain momentum, aimed at 
blocking excitotoxicity in ways superior to that 
achievable with unselective NMDA antagonists, or 
moving away from central preoccupation with 
excitotoxicity and neuronal Ca2+ overload to target other 
processes and other ionic imbalances. 
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